Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis

• Hoofdauteurs: April W. Armstrong (Auteur), Andrew F. Alexis (Auteur), Andrew Blauvelt (Auteur), Jonathan I. Silverberg (Auteur), Claire Feeney (Auteur), Mark Levenberg (Auteur), Gary Chan (Auteur), Fan Zhang (Auteur), Luke Fostvedt (Auteur)
• Formaat: Boek
• Gepubliceerd in: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Introduction Early prediction of abrocitinib efficacy in atopic dermatitis (AD) could help identify candidates for an early dose increase. A predictive model determined week 12 efficacy based on week 4 responses in patients receiving abrocitinib 100 mg/day and assessed the effect of an abro...